The last UK breast cancer (BC) human epidermal growth factor receptor 2 (HER2) testing
guideline recommendations were published in 2015. Since then, new data and therapeutic …

The standard of care for invasive cancers of the breast has been and continues to be to
evaluate them for breast prognostic markers: estrogen receptor, progesterone receptor, and …

Background Hyperinsulinemia and higher insulin-like growth factors may increase breast
cancer risk. We evaluated a diabetes risk reduction diet (DRRD) and breast cancer risk …

One of the leading causes of death (20.1 per 100,000 women per year), breast cancer is the
most prevalent cancer in females. Statistically, 95% of breast cancer are categorized as …

Simple Summary Breast cancer is not one homogeneous disease, but it includes many
subtypes that are identified in the clinical and research setting. The claudin-low subtype is a …

Abstract Heat shock factor 1 (HSF1) is a stress-responsive transcription factor that promotes
cancer cell malignancy. To provide a better understanding of the biological processes …

Background Circulating branched-chain amino acid (BCAA) levels reflect metabolic health
and dietary intake. However, associations with breast cancer are unclear. Methods We …

Purpose The recent development of multi-gene assays for gene expression profiling has
contributed significantly to the understanding of the clinically and biologically …

BACKGROUND Intrinsic molecular subtypes define distinct biological breast cancers and
can be used to further improve diagnosis and risk allocation. METHODS The Copenhagen …

Simple Summary Polyunsaturated fatty acids (PUFAs) and their derivatives, oxylipins, are a
constant focus of cancer research due to the relationship between cancer and processes of …